S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

Axsome Therapeutics (AXSM) Insider Trading & Ownership

$67.90
+2.18 (+3.32%)
(As of 04/19/2024 ET)

Axsome Therapeutics (NASDAQ:AXSM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$4.82 M
Get AXSM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Axsome Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AXSM Insider Buying and Selling by Quarter

Axsome Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/1/2024Mark L. JacobsonCOOSell24,662$77.24$1,904,892.88  
3/14/2024Roger JeffsDirectorSell29,976$69.70$2,089,327.20  
9/15/2023Mark ColemanDirectorSell11,016$75.19$828,293.04  
(Data available from 1/1/2013 forward)

AXSM Insider Trading Activity - Frequently Asked Questions

Who is on Axsome Therapeutics's Insider Roster?

The list of insiders at Axsome Therapeutics includes Mark Coleman, Mark E Saad, Mark L. Jacobson, Nick Pizzie, and Roger Jeffs. Learn more on insiders at AXSM.

What percentage of Axsome Therapeutics stock is owned by insiders?

24.50% of Axsome Therapeutics stock is owned by insiders. Learn more on AXSM's insider holdings.

Which Axsome Therapeutics insiders have been selling company stock?

The following insiders have sold AXSM shares in the last 24 months: Mark Coleman ($828,293.04), Mark L. Jacobson ($1,904,892.88), and Roger Jeffs ($2,089,327.20).

How much insider selling is happening at Axsome Therapeutics?

Insiders have sold a total of 65,654 Axsome Therapeutics shares in the last 24 months for a total of $4,822,513.12 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:AXSM) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners